
Sign up to save your podcasts
Or


Attorneys Brady Bizarro and Andrew Silverio discuss today’s senate committee hearing on GLP-1 drug pricing and strategies that self-funded employers are using to manage the extreme costs of these drugs while we wait and hope for congressional action.
By The Phia Group4.9
1717 ratings
Attorneys Brady Bizarro and Andrew Silverio discuss today’s senate committee hearing on GLP-1 drug pricing and strategies that self-funded employers are using to manage the extreme costs of these drugs while we wait and hope for congressional action.

78,307 Listeners

31,914 Listeners

227,406 Listeners

63,386 Listeners

2,245 Listeners

580 Listeners

240 Listeners

111,845 Listeners

29 Listeners

1,421 Listeners

10,106 Listeners

15,996 Listeners

36 Listeners

18,920 Listeners

15,917 Listeners